- £5.93bn
- £6.89bn
- $2.14bn
- 68
- 15
- 97
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,827 | 1,894 | 2,038 | 2,073 | 2,142 |
Cost of Revenue | |||||
Gross Profit | 973 | 1,038 | 1,130 | 1,127 | 1,201 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,730 | 1,667 | 1,834 | 1,909 | 1,880 |
Operating Profit | 96.9 | 228 | 204 | 164 | 263 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.9 | 175 | 151 | 81.9 | 167 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.8 | 113 | 118 | 62.9 | 130 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.8 | 113 | 118 | 62.9 | 130 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.8 | 113 | 118 | 62.9 | 130 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.078 | 0.07 | 0.07 | 0.098 | 0.083 |
Dividends per Share |